105 related articles for article (PubMed ID: 2798233)
1. Short-term primary culture of rat prostate tumor epithelial cells on reconstituted basement membrane as a useful in vitro model to assess drug action on prostatic cancer: efficacy of the thiazolidinedione derivative CGP 19984.
Shea WK; Black J; Ip MM
Prostate; 1989; 15(2):157-70. PubMed ID: 2798233
[TBL] [Abstract][Full Text] [Related]
2. Antitumor efficacy in rats of CGP 19984, a thiazolidinedione derivative that inhibits luteinizing hormone secretion.
Ip MM; Sylvester PW; Schenkel L
Cancer Res; 1986 Apr; 46(4 Pt 1):1735-40. PubMed ID: 3948162
[TBL] [Abstract][Full Text] [Related]
3. Effects of the thiazolidinedione derivative CGP 19984 on growth and endocrine function of the MtT-W10 transplantable mammosomatotropic pituitary tumor in female rats.
Sylvester PW; Utz PJ; Ip MM
Int J Cancer; 1988 Aug; 42(2):289-94. PubMed ID: 3403072
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
5. Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells.
Moretti RM; Montagnani Marelli M; Motta M; Limonta P
Int J Cancer; 2001 Jun; 92(5):733-7. PubMed ID: 11340580
[TBL] [Abstract][Full Text] [Related]
6. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R
J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
[TBL] [Abstract][Full Text] [Related]
7. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.
Neubauer BL; Merriman RL; Best KL; Goode RL; Sarosdy MF; Tanzer LR; Howbert JJ
J Urol; 1992 Feb; 147(2):500-4. PubMed ID: 1732631
[TBL] [Abstract][Full Text] [Related]
9. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer.
Naik HR; Lehr JE; Pienta KJ
Anticancer Res; 1994; 14(6B):2617-9. PubMed ID: 7872690
[TBL] [Abstract][Full Text] [Related]
10. Effects of polyamine analogues on prostatic adenocarcinoma cells in vitro and in vivo.
Zagaja GP; Shrivastav M; Fleig MJ; Marton LJ; Rinker-Schaeffer CW; Dolan ME
Cancer Chemother Pharmacol; 1998; 41(6):505-12. PubMed ID: 9554596
[TBL] [Abstract][Full Text] [Related]
11. Development of an in vitro clonogenic assay for the R3327 rat prostatic adenocarcinoma permits comparison of the proliferative potential of the R3327, R3327A, and R3327AT tumors.
Dibner JJ; Nakeff A
Prostate; 1983; 4(3):289-306. PubMed ID: 6844160
[TBL] [Abstract][Full Text] [Related]
12. Reconstituted basement membrane promotes morphological and functional differentiation of primary human prostatic epithelial cells.
Fong CJ; Sherwood ER; Sutkowski DM; Abu-Jawdeh GM; Yokoo H; Bauer KD; Kozlowski JM; Lee C
Prostate; 1991; 19(3):221-35. PubMed ID: 1719510
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
[TBL] [Abstract][Full Text] [Related]
14. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo.
Nguyen NM; Lehr JE; Pienta KJ
Anticancer Res; 1993; 13(6A):2143-7. PubMed ID: 7507655
[TBL] [Abstract][Full Text] [Related]
15. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Sylvester PW; Ip MM
Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of CPT-11, a new derivative of camptothecin, against human prostate cancer (PC-3) in vitro and prostate rat tumor (AT-3) in vivo.
Lievano G; Mirochnik Y; Rubenstein M; Shaw M; Guinan P
Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):659-62. PubMed ID: 9121221
[TBL] [Abstract][Full Text] [Related]
17. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
Kager M; Spruss T; Schneider MR; von Angerer E
J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
[TBL] [Abstract][Full Text] [Related]
18. The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.
Nguyen NM; Lehr JE; Shelley CI; Andersen JC; Pienta KJ
Anticancer Res; 1993; 13(6A):2053-8. PubMed ID: 7507653
[TBL] [Abstract][Full Text] [Related]
19. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
Yano T; Pinski J; Szepeshazi K; Milovanovic SR; Groot K; Schally AV
Prostate; 1992; 20(4):297-310. PubMed ID: 1351672
[TBL] [Abstract][Full Text] [Related]
20. Rhodamine-123 as effective agent in rat prostate tumor R3327-H. Preliminary report.
Arcadi JA
Urology; 1986 Dec; 28(6):501-3. PubMed ID: 3787924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
